Location History:
- Kingston, RI (US) (2016)
- New York, NY (US) (2017)
Company Filing History:
Years Active: 2016-2017
Title: Hitesh Kumar Agarwal: Innovator in Antiviral and Antimicrobial Research
Introduction
Hitesh Kumar Agarwal is a notable inventor based in New York, NY (US). He has made significant contributions to the field of antiviral and antimicrobial research, holding 2 patents that focus on innovative solutions to combat viral infections.
Latest Patents
Agarwal's latest patents include the development of substituted nucleoside derivatives with antiviral and antimicrobial properties. These inventions relate to fatty acid and fatty alcohol substituted nucleoside derivatives, as well as nucleoside derivatives substituted on multivalent scaffolds. The compounds exhibit potent anti-HIV activity and show enhanced effectiveness against multi-drug resistant, R5, and cell-associated viruses. Additionally, some derivatives demonstrate activity against other sexually transmitted pathogens and sperm. The patents provide methods of synthesis, composition of matter, and methods of use, emphasizing their application as topical microbicides to treat or prevent the sexual transmission of diseases, particularly HIV/AIDS.
Career Highlights
Throughout his career, Hitesh Kumar Agarwal has worked with esteemed institutions such as Eastern Virginia Medical School and the Board of Governors for Higher Education, State of Rhode Island and Providence Plantations. His work has significantly impacted the field of medical research and innovation.
Collaborations
Agarwal has collaborated with notable professionals in his field, including Gustavo F Doncel and Keykavous Parang. These collaborations have further enhanced his research and contributions to antiviral and antimicrobial solutions.
Conclusion
Hitesh Kumar Agarwal is a distinguished inventor whose work in developing antiviral and antimicrobial compounds is paving the way for innovative treatments. His contributions are vital in the ongoing fight against viral infections, particularly in the context of HIV/AIDS.